20561616

Michalakis KG

2010

The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction.

20562673

Klenke S

2010

A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome.

20568955

Abu Hashim H

2011

Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: a randomised controlled trial.

20569105

Castelo-Branco C

2010

Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.

20569197

Fornaro M

2010

Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders.

20571162

Mukherjee S

2010

Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.

20572369

Indhavivadhana S

2010

Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.

20573680

Melo AS

2010

High prevalence of polycystic ovary syndrome in women born small for gestational age.

20576548

Gougeon A

2010

[All about follicles...].

20576552

Robin G

2010

[Polycystic ovary syndrome: A model of follicular excess].

20576661

Peacock A

2012

Period problems: disorders of menstruation in adolescents.

20577748

Abu Hashim H

2010

Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial.

20578583

Vrb?kov? J

2010

[Is polycystic ovary syndrome a component of autoimmune disease?].

20578591

Petr?kov? J

2010

[Polycystic ovary syndrome and autoimmune diseases].

20579644

Espin?s JJ

2010

Hirsutism scoring in polycystic ovary syndrome: concordance between clinicians' and patients' self-scoring.

20586547

D?kmen E

2011

Plasma visfatin level in women with polycystic ovary syndrome.

20588246

Hao CF

2010

Evaluation of the association between the CYP19 Tetranucleotide (TTTA)n polymorphism and polycystic ovarian syndrome(PCOS) in Han Chinese women.

20590731

Liang F

2010

Acupuncture: is it effective for treatment of insulin resistance?

20591140

Teede H

2010

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.

20594551

Stadtmauer LA

2011

The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome: a prospective randomized study.

20595709

Guido M

2010

Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.

20596715

Aghahosseini M

2010

Metformin 2,500?mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile.

20597621

Genazzani AD

2010

Use of metformin in the treatment of polycystic ovary syndrome.

20598044

Hosseini MA

2010

Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.

20598902

Gonz?lez F

2010

Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome.

20604643

Barry JA

2010

Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels.

20604657

Sharami SH

2010

Randomised clinical trial of the influence of pulmonary recruitment manoeuvre on reducing shoulder pain after laparoscopy.

20607008

Jayakrishnan K

2010

Endometrial carcinoma in a young subfertile woman with polycystic ovarian syndrome.

20608809

Amato MC

2011

Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome.

20610596

Dewailly D

2010

Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-M?llerian hormone concentrations aggregate with the markers of hyperandrogenism.

20618344

Alvarez-Blasco F

2010

Obesity impairs general health-related quality of life (HR-QoL) in premenopausal women to a greater extent than polycystic ovary syndrome (PCOS).

20618496

Kelekci KH

2010

Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.

20618560

Maluki AH

2010

The frequency of polycystic ovary syndrome in females with resistant acne vulgaris.

20620158

Plaza F

2010

The conversion of dehydroepiandrosterone into androst-5-ene-3beta,17beta-diol (androstenediol) is increased in endometria from untreated women with polycystic ovarian syndrome.

20622344

Mohamadin AM

2010

Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine.

20624011

Genazzani AD

2010

Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS.

20626239

Cakal E

2011

Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome.

20626240

Hanjalic-Beck A

2010

Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.

20630102

V?zquez-Cuevas FG

2010

Functional expression and intracellular signaling of UTP-sensitive P2Y receptors in theca-interstitial cells.

20630504

Raja-Khan N

2010

A variant in the fibrillin-3 gene is associated with TGF-? and inhibin B levels in women with polycystic ovary syndrome.

20634211

Kelly CJ

2011

Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis.

20636232

Nejad ES

2011

Comparison of in vitro fertilisation success in patients with polycystic ovary syndrome and tubal factor.

20638057

Ott J

2010

Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome.

20638059

Kamath MS

2010

Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial.

20639519

Qiao J

2011

Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

20642261

Keller DL

2010

Risks related to the use of finasteride (propecia) in pregnant women.

20642382

Battaglia C

2010

L-arginine plus drospirenone-ethinyl estradiol in the treatment of patients with PCOS: a prospective, placebo controlled, randomised, pilot study.

20645396

Lujan ME

2010

Development of morphologically dominant follicles is associated with fewer metabolic disturbances in amenorrheic women with polycystic ovary syndrome: a pilot study.

20645890

Gingnell M

2011

Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women.

20645891

de S? JC

2011

Analysis of heart rate variability in polycystic ovary syndrome.

20647214

Utz AL

2010

Case records of the Massachusetts General Hospital. Case 20-2010. A 32-year-old woman with oligomenorrhea and infertility.

20649035

Liu X

2010

[On the relationship between serum total adiponectin and insulin resistance in polycystic ovary syndrome].

20650451

Codner E

2011

Polycystic ovarian morphology in postmenarchal adolescents.

20654753

Uras R

2010

Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.

20654754

Kriplani A

2010

Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.

20655529

Pesant MH

2011

Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome.

20658732

Nersesyan A

2010

Micronuclei and other nuclear anomalies levels in exfoliated buccal cells and DNA damage in leukocytes of patients with polycystic ovary syndrome.

20659909

Harris SE

2010

Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome.

20660041

Gambineri A

2010

Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome.

20660045

Grynberg M

2010

Female gonadal function before and after treatment of acromegaly.

20660051

Ketel IJ

2010

Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity--but not a PCOS-associated phenomenon.

20663178

Falbo A

2010

Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin.

20663984

Johansson J

2010

Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.

20667406

Doblado MA

2010

In vitro fertilization after bariatric surgery.

20671408

Savastano S

2010

Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome.

20674135

Sharma A

2010

National survey on management of weight reduction in PCOS women in the United Kingdom.

20682841

Abbott DH

2010

Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring.

20684953

Wu CH

2010

Androgen excess down-regulates connexin43 in a human granulosa cell line.

20684955

Naka KK

2011

Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study.

20687400

Jinno M

2010

Low-dose metformin improves pregnancy rate in in vitro fertilization repeaters without polycystic ovary syndrome: prediction of effectiveness by multiple parameters related to insulin resistance.

20691435

D?az M

2010

Efficacy of metformin therapy in adolescent girls with androgen excess: relation to sex hormone-binding globulin and androgen receptor polymorphisms.

20694489

Diamanti-Kandarakis E

2011

Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome.

20695761

T?rk??o?lu I

2011

Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome.

20695771

Verhaeghe J

2010

Hormonal contraception in women with the metabolic syndrome: a narrative review.

20696094

O'Connor A

2010

Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet.

20697141

Savchev SI

2010

Follicular fluid-specific distribution of vascular endothelial growth factor isoforms and sFlt-1 in patients undergoing IVF and their correlation with treatment outcomes.

20697943

Li Q

2010

Effects of Bushen Tongmai Recipe on protein kinase Balpha expression in polycystic ovary rats with insulin resistance.

20701906

Caglar GS

2011

Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance.

20705157

De Leo V

2010

Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.

20705511

Wang B

2010

Identification of novel missense mutations of GDF9 in Chinese women with polycystic ovary syndrome.

20708064

Repaci A

2011

The role of low-grade inflammation in the polycystic ovary syndrome.

20708160

Oliveira A

2010

Polycystic ovary syndrome: challenges in adolescence.

20709580

Karcaaltincaba D

2011

Gestational diabetes and gestational impaired glucose tolerance in 1653 teenage pregnancies: prevalence, risk factors and pregnancy outcomes.

20712252

Katulski K

2010

[Natural history of polycyclic ovary syndrome].

20713501

Roland AV

2010

Prenatal androgen exposure programs metabolic dysfunction in female mice.

20716558

Zhang H

2010

Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome.

20716614

Assou S

2011

Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applications.

20719841

Johnstone EB

2010

The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.

20720262

Patel SS

2010

17?-Hydroxylase (CYP17) expression and subsequent androstenedione production in the human ovary.

20720468

Ahonen KA

2010

Polycystic ovary syndrome: recognize and intervene early.

20720595

Bose CK

2009

Neurotrophin in obstetrics and gynaecology.

20723258

Morales-Ledesma L

2010

Unilateral sectioning of the superior ovarian nerve of rats with polycystic ovarian syndrome restores ovulation in the innervated ovary.

20724929

Katsiki N

2010

Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.

20726452

Lumb A

2010

Expanding boundaries of endocrinology.

20730705

Luque-Ram?rez M

2010

Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations.

20734064

He C

2010

A large-scale candidate gene association study of age at menarche and age at natural menopause.

20734639

Kavardzhikova S

2010

[Clinical, hormonal and metabolic characteristics of different phenotypes of polycystic ovary syndrome, in Bulgarian population].

20734654

Pechlivanov B

2010

[Myo-inositol in the treatment of hormonal, metabolic and reproductive features of polycystic ovary syndrome (review of the literature].

20734696

Pembe AB

2009

Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania.

20739662

Veiga-Lopez A

2011

Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep.